Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Gross Profit (2019 - 2025)

Historic Gross Profit for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $17.7 million.

  • Biodesix's Gross Profit rose 2641.0% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.0 million, marking a year-over-year increase of 2557.84%. This contributed to the annual value of $55.8 million for FY2024, which is 5453.06% up from last year.
  • Biodesix's Gross Profit amounted to $17.7 million in Q3 2025, which was up 2641.0% from $16.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Gross Profit ranged from a high of $17.7 million in Q3 2025 and a low of $3.3 million during Q1 2022
  • For the 5-year period, Biodesix's Gross Profit averaged around $9.9 million, with its median value being $10.3 million (2023).
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 20293.03% in 2021, then crashed by 6888.62% in 2022.
  • Biodesix's Gross Profit (Quarter) stood at $4.7 million in 2021, then skyrocketed by 33.19% to $6.3 million in 2022, then surged by 79.24% to $11.3 million in 2023, then surged by 42.44% to $16.1 million in 2024, then rose by 9.79% to $17.7 million in 2025.
  • Its Gross Profit stands at $17.7 million for Q3 2025, versus $16.0 million for Q2 2025 and $14.3 million for Q1 2025.